A Study to Assess the Safety and Efficacy of LB-P8 in Patients With PSC

Status:
NOT_YET_RECRUITING

Trial end date:
2029-02-01

Target enrollment:

Participant gender:

The study is designed to assess the safety and efficacy of LB-P8 in patients with primary sclerosing cholangitis.

PHASE2

LISCure Biosciences